Overview
Diabetes and pregnancy refers to the management of disordered glucose metabolism during gestation, encompassing both pre-existing diabetes and gestational diabetes mellitus, the latter defined as glucose intolerance first recognized in pregnancy. The condition arises when the physiological insulin resistance of pregnancy, driven by placental hormones, is not matched by sufficient insulin secretion, producing maternal hyperglycemia. Because glucose crosses the placenta while insulin does not, sustained maternal hyperglycemia stimulates fetal insulin production and can result in fetal overgrowth, or macrosomia, alongside risks of birth trauma, neonatal hypoglycemia, and later metabolic disease in the offspring. Maternal consequences include hypertensive disorders, increased rates of operative delivery, and a heightened lifetime risk of type 2 diabetes. Identification of risk factors and systematic screening allow timely diagnosis, and outcomes improve substantially with treatment, whether through dietary modification, glucose monitoring, or pharmacologic therapy. Research in this area also examines the inflammatory milieu of gestational diabetes, including proinflammatory cytokines that accompany insulin resistance, and the intersection of metabolic disease with social and psychological stressors that influence glycemic control. Preconception counseling and care further reduce risk by optimizing glucose regulation before conception. Effective management across the preconception, antenatal, and postpartum periods is central to reducing both immediate obstetric complications and the longer-term health consequences for mother and child.
Research published in this journal
8 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Pregnancy Outcome in Gestational Diabetes Mellitus under Treatment-Bangladesh Perspective
Association of Risk Factors in Gestational Diabetes Mellitus among Pregnant Mothers Attending at a Tertiary Care Hospital in Bangladesh
Association of Gestational Diabetes and Proinflammatory Cytokines (IL-6, TNF-α and IL-1β)
Below What Hemoglobin Concentration in Pregnancy is there an Increased Risk of Maternal or Fetal Adverse Effects?
Knowledge And Practice of Preconception Care Among Women of Reproductive-Age in Bheerkot Municipality, Nepal
Intersecting Epidemics: Intimate Partner Violence, Stress, and Diabetes Among South Asian Women in the United States
Surgical Site Infection in Cesarean Section Operation: Risk and Management
How this research is being cited
The 8 articles above have been cited 24 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
T. Tofail et al. · 2025 · Egyptian Journal of Medical Human Genetics
-
Asma Shaheen et al. · 2025 · Journal of Diabetology
-
2025 · Journal of Diabetology
-
2025 · Egyptian Journal of Medical Human Genetics
-
Aditya Gan et al. · 2024 · Maternal-Fetal Medicine
-
2024 · medRxiv (Cold Spring Harbor Laboratory)
-
S. Aryal et al. · 2024 · medRxiv
-
F. Beyene et al. · 2023 · European Journal of Medical Research
A sample of recent works citing this journal's research on Diabetes and Pregnancy, linking to each citing work.